Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer

Condition:   Breast Cancer Intervention:   Drug: nab-paclitaxel Sponsor:   Chinese Academy of Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials